Consult our studies
Resources
Discover OWL Metabolomics contribution to scientific knowledge in our Resources section. We invite you to consult the publications in which we have participated, offering crucial insights into different therapeutic areas. Our library is here to help you with your research needs. We encourage you to explore our contributions with our extensive resources at your disposal. Use the filter options to search information by year of publication, therapeutic area, and/or disease.
Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis
Obesity Surgery 2024;34:841-9
/ 2024
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Caenorhabditis elegans RAC1/ced-10 mutants as a new animal model to study very early stages of Parkinson’s disease
Prog Neurobiol 2024;234:102572
/ 2024
Area: Neuroscience
Disease: Parkinson’s Disease
Area: Neuroscience
Disease: Parkinson’s Disease
Dietary ω3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study.
Nutrients 2023;15(16):3637.
/ 2023
Area: Cardiology / Cardiovascular
Disease: Cardiovascular disease
Area: Cardiology / Cardiovascular
Disease: Cardiovascular disease
Impaired hepatic VLDL secretion promotes tumorigenesis and is accelerated with Fabp1 deletion
Am J Pathol (in press).
/ 2024
Area: Oncology and Gastroenterology / Hepatology
Disease: MASLD/MASH and Hepatocellular carcinoma
Area: Oncology and Gastroenterology / Hepatology
Disease: MASLD/MASH and Hepatocellular carcinoma
Lipidomics and biodistribution of extracellular vesicles-secreted by hepatocytes from Zucker lean and fatty rats
J of Extracellular Bio 2024;3:e140
/ 2024
Area: Metabolomics
Disease: Obesity
Area: Metabolomics
Disease: Obesity
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study.
Hepatology 2023;78(1):258-71
/ 2023
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Serum identification of At-Risk MASH: The Metabolomics-Advanced steatohepatitis fibrosis score (MASEF).
Hepatology 2023;79(1):135-148.
/ 2024
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells
The Spine Journal 2023;23(10):1549-62
/ 2023
Area: Neuroscience
Disease: Intervertebral disc degeneration
Area: Neuroscience
Disease: Intervertebral disc degeneration
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant. data meta-analysis
Lancet Gastroenterol Hepatol 2023; 8(8):704-13.
/ 2023
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Liver International 2023;43(3):2256-74
/ 2023
Area: Oncology and Gastroenterology / Hepatology
Disease: MASLD/MASH and Hepatocellular carcinoma
Area: Oncology and Gastroenterology / Hepatology
Disease: MASLD/MASH and Hepatocellular carcinoma
Serum lipidome unravels a diagnostic potential in bile acid diarrhoea.
Lewinska M, et al. Gut 2023;72(9):1698-708.
/ 2023
Area: Gastroenterology / Hepatology
Disease: Bile acid diarrhoea
Area: Gastroenterology / Hepatology
Disease: Bile acid diarrhoea
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes.
Biomedicines 2023;11(2):337.
/ 2023
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
Area: Gastroenterology / Hepatology
Disease: MASLD/MASH
